Be The Investor

After Hours7,697.52+0.11%

Nasdaq Composite

25,736.51+1.44%

After Hours25,732.01-0.02%

53,356.12+3.03%

After Hours53,431.91+0.14%

After Hours2,861.04+0.14%

80,615.24+4.24%

US 10-Year Treasury Yield

Home›Stocks›CERE

Overview Chart News Financials Business Model Competitors Statistics Analysis Earnings Valuation Holders Options Insiders Forecast Compare FAQ

Cerevel Therapeutics Holdings, Inc.

CERE

NASDAQ

USReal-Time Price

$44.96USD

+0.33 (+0.74%)Today

After Hours · No saved quote available

BTI Score

BASIC required or higher

BTI Fair Market Cap

Valuation unavailable

Biotechnology

High Risk

Cerevel Therapeutics Holdings, Inc. (CERE) Business Model

How does Cerevel Therapeutics Holdings, Inc. (CERE) make money? A breakdown of revenue segments, margins, competitive moat and the unit economics behind the business.

Error loading business model: Sign in to load this business model